维普中文期刊产品整合服务
10篇 您的检索式:作者名="Sambuelli"
    题名 作者 年代 出处 被引量
1Budesonide enema in pouchitis-a double-blind,double-dummy,controlled trial显示文摘Sambuelli A Boerr L Negreira S 2002Alimentary Pharmacology&Therapeutics2002,16,1:1
2Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors显示文摘Guglielmone H Sambuelli R Echenique JR 2000Eur J Ophthalmol2000,10,:1
3Bacillary angiomatosis affecting the oral cavity: Report of two cases and review 显示文摘Lopez de Blanc S Sambuelli R 2000J Oral Pathol Med2000,29,1:1
4Multidrug resistance gene (MDRI) expression in the colonic mucosa of patients with refractory ulcerative colitis显示文摘Sambuelli AM Negreira SM Gil AH 0,,01:1
5Budesonide enema in pouchitis-a double-blind,double-dummy,controlled trial显示文摘Sambuelli A Boerr L Negreira S 2002Aliment Pharmacol Ther2002,16,1:1
6Theoretical derivation of a peak particle velocity- distance law for the prediction of vibrations from blasting 显示文摘Sambuelli L 2009Rock Mech Rock Eng2009,42,3:1
7Small choroidal melanoma with massive extraocular extension:invasion through posterior scleral emissary channels显示文摘Sambuelli R Luna J D Reviglio V E 0,,04:1
8Multidrug resistance gene (MDR-1) expression in the colonic mucosa of patients with refractory ulcerative colitis显示文摘Sambuelli AM Negreira SM Gil AH 0,,01:1
9Tomographie ultrasonore pour les arbressur pied Ann显示文摘Martinis R Socoo L V Sambuelli L 0,,:1
10Blockade of Rho-associated kinase prevents inhibition of axon regeneration of peripheral nerves induced by anti-ganglioside antibodies显示文摘Anti-ganglioside antibodies are associated with delayed/poor clinical recovery in Guillain-Barrèsyndrome,mostly related to halted axon regeneration.Cross-linking of cell surface gangliosides by anti-ganglioside antibodies triggers inhibition of nerve repair in in vitro and in vivo paradigms of axon regeneration.These effects involve the activation of the small GTPase Rho A/ROCK signaling pathways,which negatively modulate growth cone cytoskeleton,similarly to well stablished inhibitors of axon regeneration described so far.The aim of this work was to perform a proof of concept study to demonstrate the effectiveness of Y-27632,a selective pharmacological inhibitor of ROCK,in a mouse model of axon regeneration of peripheral nerves,where the passive immunization with a monoclonal antibody targeting gangliosides GD1a and GT1b was previously reported to exert a potent inhibitory effect on regeneration of both myelinated and unmyelinated fibers.Our results demonstrate a differential sensitivity of myelinated and unmyelinated axons to the pro-regenerative effect of Y-27632.Treatment with a total dosage of 9 mg/kg of Y-27632 resulted in a complete prevention of anti-GD1a/GT1b monoclonal antibody-mediated inhibition of axon regeneration of unmyelinated fibers to skin and the functional recovery of mechanical cutaneous sensitivity.In contrast,the same dose showed toxic effects on the regeneration of myelinated fibers.Interestingly,scale down of the dosage of Y-27632 to 5 mg/kg resulted in a significant although not complete recovery of regenerated myelinated axons exposed to anti-GD1a/GT1b monoclonal antibody in the absence of toxicity in animals exposed to only Y-27632.Overall,these findings confirm the in vivo participation of Rho A/ROCK signaling pathways in the molecular mechanisms associated with the inhibition of axon regeneration induced by anti-GD1a/GT1b monoclonal antibody.Our findings open the possibility of therapeutic pharmacological intervention targeting Rho A/Rock pathway in immune neuropathies associated with the presence of anti-ganglioside antibodies and delayed or incomplete clinical recovery after injury in the peripheral nervous system.Andrés Berardo Cristian R.Bacaglio Bárbara B.Báez Rubén Sambuelli Kazim A.Sheikh Pablo H.H.Lopez 2024Neural Regeneration Research2024,19,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费